This trial is testing a new combination of drugs to treat bladder cancer. If it is successful, it could help people preserve their Bladders and avoid surgery.
1 Primary · 3 Secondary · Reporting Duration: up to 5 years
Experimental Treatment
71 Total Participants · 1 Treatment Group
Primary Treatment: AMVAC + Nivolumab · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: